Our previous study and other studies have identified that human MDSCs from solid tumors or multiple myeloma can suppress anti-CD3-induced autologous or allogeneic T cell proliferation, including CD4+ and CD8+ T cells. This evidence concerns the gene CD4 and plasma cell myeloma.